IP Library › Assignment 024049/0455
Patent Assignment
Reel/Frame 024049/0455

Assignment of Assignor's Interest

Recorded: 2010-03-09 Pages: 18
Assignors
ROSKAMP RESEARCH LLC
Executed: 2010-01-29
ARCHER PHARMACEUTICALS, INC.
Executed: 2010-01-29
Assignee
ALZHEIMER'S INSTITUTE OF AMERICA, INC.
7837 PARALLEL PARKWAY, KANSAS CITY, KANSAS, 66112
Covered Property (1)
Method for Reducing Amyloid Deposition, Amyloid Neurotoxicity, and Microgliosis with (-)-Nilvadipine Enantiomer
Patent: 8,236,346 →
Application: 12/245,354 →
Publication: US 2009/0092667
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 4, 2008
From: MULLAN, MICHAEL J.; PARIS, DANIEL; IVEY, ROBERT A., III
To: ROSKAMP RESEARCH LLC
Reel/Frame 021944/0437 →
Assignment of Assignor's Interest Feb 13, 2017
From: AIA AMERICA, INC.
To: ARCHER PHARMACEUTICALS, INC.
Reel/Frame 041233/0541 →
Grant of Security Interest in United States Patents Feb 13, 2017
From: ARCHER PHARMACEUTICALS, INC.
To: AIA AMERICA, INC.
Reel/Frame 041689/0945 →